Botulinum toxin injections offer an alternative to extraocular muscle surgery for comitant esotropia
March 5th 2023According to researchers, the treatment with botulinum toxin is safe, fast-acting, and improves both cosmetic appearance and quality of life, and could be considered as a choice for patients not opting for surgery.
Read More
Study: Fovea-involving half dose of PDT proves a safe, long-term treatment option for chronic CSC
March 3rd 2023According to researchers, patients with chronic CSC treated with 1 fovea-involving, half-dose PTD application had a significant improvement in structure and function at the final follow-up and foveal atrophy did not develop in any patients.
Read More
Incision Enlargement with Injection of IOLs during Cataract Surgery: Size Does Matter
February 27th 2023The study compared 126 IOL injectors of 13 IOL injector systems regarding the manufacturers’ recommended preoperative incision sizes to evaluate the intraoperative incision enlargement and postoperative incision sizes.
Read More
EnVision Summit 2023: Baseline dry eye status may dictate choice between LASIK and PRK
February 20th 2023In a presentation at the EnVision Summit 2023 in Puerto Rico, Sumayya Ahmad, MD, pointed out that for patients with lower Schirmer’s scores and corneal staining, PRK may be a good choice. If the dry eye can be treated preoperatively and the eye has no staining, surgeons can consider LASIK.
Read More
EnVision Summit 2023: The challenges of tube shunts for glaucoma in pediatric eyes
February 17th 2023During a presentation at the EnVision Summit Ophthalmology 2023 at El Conquistador Resort in Puerto Rico, Elena Bitrian, MD, outlines the challenges that surgeons are confronted with surgically in pediatric eyes, including the limited working space and palpebral fissure, axial length, and avoidance of the thin sclera and shallow scleral pass.
Read More
Angiogenesis 2023: Visual functional loss in geographic atrophy
February 10th 2023In a presentation at the 2023 Angiogenesis, Exudation, and Degeneration program, Usha Chakravarthy, PhD, FRCOphth, CBE, presented data from the trial of lampalizumab, which is peeling back some of the mystery shrouding geographic atrophy.
Read More
Angiogenesis 2023: Ophthalmic artery angioplasty to treat age-related macular degeneration
February 10th 2023In a presentation at Bascom Palmer’s 2023 Angiogenesis, Exudation, and Degeneration conference in Miami, Pedro Lylyk, MD, said ophthalmic artery angioplasty could prove to be a treatment option for patients diagnosed with age-related macular degeneration.
Read More